Advance will enable PharmaDiagnostics to maximize commercial potential of label-free screening technology Brussels, December 11, 2009 - PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today that it has been granted a US patent covering its nanoparticle/conductive polymer composites. The patent is entitled “Stable metal/conductive polymer composite colloids and methods for making and using the same”.

Label-free screening company looks to accelerate growth by strengthening commercial and R&D team Brussels, October 12, 2009 - PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today that it has successfully secured further funding of EUR 2.5 million (USD 3.5M) from its initial investors.

Ricketts brings wide international industry experience to labelfree screening company Brussels, October 12, 2009--PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today that it has appointed Dr David Ricketts as chief executive officer. The company also announces today that it has raised EUR 2.5 million in a second round of funding.